InflaRx (IFRX) Sales of Property, Plant and Equipment (2018 - 2025)
InflaRx (IFRX) Sales of Property, Plant and Equipment (2018 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.85 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 698,426.11 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | 14.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15.52 Mn |
| Sep 30, 2025 | 15.52 Mn |
| Jun 30, 2025 | 12.02 Mn |
| Jun 30, 2025 | 12.02 Mn |
| Mar 31, 2025 | 18.58 Mn |
| Mar 31, 2025 | 18.58 Mn |
| Sep 30, 2024 | 24.22 Mn |
| Sep 30, 2024 | 24.22 Mn |
| Jun 30, 2024 | 27.67 Mn |
| Jun 30, 2024 | 27.67 Mn |
| Mar 31, 2024 | 33.16 Mn |
| Mar 31, 2024 | 33.16 Mn |
| Sep 30, 2023 | 17.32 Mn |
| Sep 30, 2023 | 17.32 Mn |
| Jun 30, 2023 | 36.66 Mn |
| Jun 30, 2023 | 36.66 Mn |
| Mar 31, 2023 | 23.12 Mn |
| Mar 31, 2023 | 23.12 Mn |
| Sep 30, 2022 | 5.05 Mn |
| Sep 30, 2022 | 5.05 Mn |